1 |
Namakchian M, Rabizadeh S, Seifouri S, Asadigandomani H, Bafrani MA, Seifouri K, Avanaki FA, Rajab A, Nakhjavani M, Esteghamati A. Fibrosis score 4 index has an independent relationship with coronary artery diseases in patients with metabolic-associated fatty liver disease. Diabetol Metab Syndr 2023;15:57. [PMID: 36964605 DOI: 10.1186/s13098-023-01031-y] [Reference Citation Analysis]
|
2 |
Wu JY, Tsai YS, Li CC, Yeh ML, Huang CI, Huang CF, Hsu JN, Hsieh MH, Chen YC, Liu TW, Lin YH, Liang PC, Lin ZY, Chuang WL, Yu ML, Dai CY. Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Treatment. Biomedicines 2022;10. [PMID: 36359344 DOI: 10.3390/biomedicines10112824] [Reference Citation Analysis]
|
3 |
Chan WK, Tan SS, Chan SP, Lee YY, Tee HP, Mahadeva S, Goh KL, Ramli AS, Mustapha F, Kosai NR, Raja Ali RA. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease. J Gastroenterol Hepatol 2022;37:795-811. [PMID: 35080048 DOI: 10.1111/jgh.15787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Kariyama K, Kawanaka M, Nouso K, Hiraoka A, Toyoda H, Tada T, Ishikawa T, Wakuta A, Miyake N, Murakami S, Shiota S, Kumada T. Fibrosis-3 Index: A New Score to Predict Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Without Age as a Factor. Gastro Hep Advances 2022;1:1108-1113. [DOI: 10.1016/j.gastha.2022.07.012] [Reference Citation Analysis]
|